WHO ICTRP trial
Cannabidiol as a treatment in patients with movement disorder
RBR-36x4c4d · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-36x4c4d |
|---|---|
| Public title | Cannabidiol as a treatment in patients with movement disorder |
| Scientific title | Cannabidiol as a therapy for spinocerebellar ataxia |
| Primary sponsor | Universidade Federal do Paraná |
| Secondary sponsors | Universidade Federal do Paraná |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Phase | 1 |
| Countries | Brazil |
| Conditions | Spinocerebellar Ataxia;C10.228.140.252.190 |
| Interventions | This is a single-blind clinical trial, in which participants will be informed and will need to agree and sign that they may receive placebo medication or pure cannabidiol extract, but all will receive pure cannabidiol extract and will be… |
| Registration date | Nov 7, 2023 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: